We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: The new partnership will explore development of solutions to aid the diagnosis of TBI (Photo courtesy of Roche)

Roche to Develop New Diagnostic Technologies for Traumatic Brain Injuries

Roche has entered into a partnership with the U.S. BARDA Burn and Blast Medical Countermeasures Program to drive innovation in the diagnosis of traumatic brain injuries which affect about 69 million people each year. More...
14 Oct 2024
Image: The test aims to detect 12 of the most lethal and common cancers at an early stage (Photo courtesy of AdobeStock)

MicroRNA-Based Test Identifies 12 Cancers Simultaneously Across Any Stage

A new blood-based, multi-cancer diagnostic test aims to detect 12 of the deadliest and most common cancers at an early stage before symptoms appear. More...
14 Oct 2024
Image: New research promises a potential non-invasive stool test and novel therapy for endometriosis (Photo courtesy of Shutterstock)

Non-Invasive Stool Test to Diagnose Endometriosis and Help Reduce Disease Progression

Researchers have made promising discoveries that could pave the way for a non-invasive stool test and a new treatment option for endometriosis, a painful condition impacting nearly 200 million women globally. More...
14 Oct 2024
Image: The partnership will accelerate the adoption of AccuGenomics’ Accukit ctDNA MRD IS and Accukit Myeloid DNA IS (Photo courtesy of AccuGenomics)

LGC Clinical Diagnostics and AccuGenomics Collaborate on Enhancing Cancer Testing Accuracy

LGC and AccuGenomics have entered into a new strategic partnership to combine LGC’s expertise in quality control solutions with AccuGenomics’ advanced NGS monitoring technologies, driving innovation in clinical diagnostic tools. More...
11 Oct 2024
Image: Bone marrow affected by multiple myeloma, a disease against which PVR inhibition can increase the efficacy of immunotherapy (Photo courtesy of Cancer Epigenetics Group, IJC)

Epigenetic Test Could Determine Efficacy of New Immunotherapy Treatments Against Multiple Myeloma

Researchers have demonstrated an epigenetic test that predicts the effectiveness of new immunotherapy treatments for multiple myeloma, a blood cancer primarily affecting individuals over sixty. More...
11 Oct 2024
Image: Scientists have validated a new lab test platform for blood biomarkers of Alzheimer’s disease (Photo courtesy of 123RF)

New Blood Test Platform Simultaneously Measures Over 100 Biomarkers of Alzheimer's Disease

Scientists have independently validated a new blood test platform capable of measuring over 100 biomarkers related to Alzheimer’s disease that could improve the ability of clinicians to capture the disease's complex pathology. More...
11 Oct 2024
Image: Bone marrow affected by multiple myeloma, a disease against which PVR inhibition can increase the efficacy of immunotherapy (Photo courtesy of Cancer Epigenetics Group, IJC)

Epigenetic Test Could Determine Efficacy of New Immunotherapy Treatments Against Multiple Myeloma

Researchers have demonstrated an epigenetic test that predicts the effectiveness of new immunotherapy treatments for multiple myeloma, a blood cancer primarily affecting individuals over sixty. More...
11 Oct 2024
Visit expo >
Gold Member
Rickettsia Conorii Assay
RICKETTSIA CONORII ELISA
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Dengue Virus Immunochromatographic Assay
STANDARD Q Dengue IgM/IgG Test
New
Vedolizumab ELISA
RIDASCREEN VDZ Monitoring

In Other News

Copyright © 2000 - 2024 Globetech Media.
All rights reserved.